Batch Release Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512248139

Publication Date:

December 9, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

The manufacturing process of pharmaceuticals, biologics or medical devices requires batch release testing to ensure high quality products prior to market release.
The global market for Batch Release Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Batch Release Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Batch Release Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Batch Release Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Batch Release Testing include Wuxi Biologics, Merk, Eurofins BioPharma Product Testing, Samsung Biologics, Texcell, Intertek Group plc, ALS Life Sciences Europe, Kymos and Selvita, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Batch Release Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Batch Release Testing by region & country, by Type, and by Application.
The Batch Release Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Batch Release Testing.
Market Segmentation
By Company
Wuxi Biologics
Merk
Eurofins BioPharma Product Testing
Samsung Biologics
Texcell
Intertek Group plc
ALS Life Sciences Europe
Kymos
Selvita
Excite Pharma Services
Smithers
BSL BIOSERVICE Scientific Laboratories Munich GmbH
FDAS
ALS Laboratories (UK) Limited
ADOH BV
Segment by Type:
Full Batch Release
Sampling Release
Segment by Application
Biopharmaceutical
Scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Batch Release Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Batch Release Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Batch Release Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Batch Release Testing Product Introduction
1.2 Global Batch Release Testing Market Size Forecast
1.3 Batch Release Testing Market Trends & Drivers
1.3.1 Batch Release Testing Industry Trends
1.3.2 Batch Release Testing Market Drivers & Opportunity
1.3.3 Batch Release Testing Market Challenges
1.3.4 Batch Release Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Batch Release Testing Players Revenue Ranking (2023)
2.2 Global Batch Release Testing Revenue by Company (2019-2024)
2.3 Key Companies Batch Release Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Batch Release Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Batch Release Testing
2.6 Batch Release Testing Market Competitive Analysis
2.6.1 Batch Release Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Batch Release Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Batch Release Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Full Batch Release
3.1.2 Sampling Release
3.2 Global Batch Release Testing Sales Value by Type
3.2.1 Global Batch Release Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Batch Release Testing Sales Value, by Type (2019-2030)
3.2.3 Global Batch Release Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biopharmaceutical
4.1.2 Scientific Research
4.2 Global Batch Release Testing Sales Value by Application
4.2.1 Global Batch Release Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Batch Release Testing Sales Value, by Application (2019-2030)
4.2.3 Global Batch Release Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Batch Release Testing Sales Value by Region
5.1.1 Global Batch Release Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Batch Release Testing Sales Value by Region (2019-2024)
5.1.3 Global Batch Release Testing Sales Value by Region (2025-2030)
5.1.4 Global Batch Release Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Batch Release Testing Sales Value, 2019-2030
5.2.2 North America Batch Release Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Batch Release Testing Sales Value, 2019-2030
5.3.2 Europe Batch Release Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Batch Release Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Batch Release Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Batch Release Testing Sales Value, 2019-2030
5.5.2 South America Batch Release Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Batch Release Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Batch Release Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Batch Release Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Batch Release Testing Sales Value
6.3 United States
6.3.1 United States Batch Release Testing Sales Value, 2019-2030
6.3.2 United States Batch Release Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Batch Release Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Batch Release Testing Sales Value, 2019-2030
6.4.2 Europe Batch Release Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Batch Release Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Batch Release Testing Sales Value, 2019-2030
6.5.2 China Batch Release Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Batch Release Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Batch Release Testing Sales Value, 2019-2030
6.6.2 Japan Batch Release Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Batch Release Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Batch Release Testing Sales Value, 2019-2030
6.7.2 South Korea Batch Release Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Batch Release Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Batch Release Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Batch Release Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Batch Release Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Batch Release Testing Sales Value, 2019-2030
6.9.2 India Batch Release Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Batch Release Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Wuxi Biologics
7.1.1 Wuxi Biologics Profile
7.1.2 Wuxi Biologics Main Business
7.1.3 Wuxi Biologics Batch Release Testing Products, Services and Solutions
7.1.4 Wuxi Biologics Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Wuxi Biologics Recent Developments
7.2 Merk
7.2.1 Merk Profile
7.2.2 Merk Main Business
7.2.3 Merk Batch Release Testing Products, Services and Solutions
7.2.4 Merk Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Merk Recent Developments
7.3 Eurofins BioPharma Product Testing
7.3.1 Eurofins BioPharma Product Testing Profile
7.3.2 Eurofins BioPharma Product Testing Main Business
7.3.3 Eurofins BioPharma Product Testing Batch Release Testing Products, Services and Solutions
7.3.4 Eurofins BioPharma Product Testing Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Samsung Biologics Recent Developments
7.4 Samsung Biologics
7.4.1 Samsung Biologics Profile
7.4.2 Samsung Biologics Main Business
7.4.3 Samsung Biologics Batch Release Testing Products, Services and Solutions
7.4.4 Samsung Biologics Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Samsung Biologics Recent Developments
7.5 Texcell
7.5.1 Texcell Profile
7.5.2 Texcell Main Business
7.5.3 Texcell Batch Release Testing Products, Services and Solutions
7.5.4 Texcell Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.5.5 Texcell Recent Developments
7.6 Intertek Group plc
7.6.1 Intertek Group plc Profile
7.6.2 Intertek Group plc Main Business
7.6.3 Intertek Group plc Batch Release Testing Products, Services and Solutions
7.6.4 Intertek Group plc Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.6.5 Intertek Group plc Recent Developments
7.7 ALS Life Sciences Europe
7.7.1 ALS Life Sciences Europe Profile
7.7.2 ALS Life Sciences Europe Main Business
7.7.3 ALS Life Sciences Europe Batch Release Testing Products, Services and Solutions
7.7.4 ALS Life Sciences Europe Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.7.5 ALS Life Sciences Europe Recent Developments
7.8 Kymos
7.8.1 Kymos Profile
7.8.2 Kymos Main Business
7.8.3 Kymos Batch Release Testing Products, Services and Solutions
7.8.4 Kymos Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Kymos Recent Developments
7.9 Selvita
7.9.1 Selvita Profile
7.9.2 Selvita Main Business
7.9.3 Selvita Batch Release Testing Products, Services and Solutions
7.9.4 Selvita Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Selvita Recent Developments
7.10 Excite Pharma Services
7.10.1 Excite Pharma Services Profile
7.10.2 Excite Pharma Services Main Business
7.10.3 Excite Pharma Services Batch Release Testing Products, Services and Solutions
7.10.4 Excite Pharma Services Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.10.5 Excite Pharma Services Recent Developments
7.11 Smithers
7.11.1 Smithers Profile
7.11.2 Smithers Main Business
7.11.3 Smithers Batch Release Testing Products, Services and Solutions
7.11.4 Smithers Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Smithers Recent Developments
7.12 BSL BIOSERVICE Scientific Laboratories Munich GmbH
7.12.1 BSL BIOSERVICE Scientific Laboratories Munich GmbH Profile
7.12.2 BSL BIOSERVICE Scientific Laboratories Munich GmbH Main Business
7.12.3 BSL BIOSERVICE Scientific Laboratories Munich GmbH Batch Release Testing Products, Services and Solutions
7.12.4 BSL BIOSERVICE Scientific Laboratories Munich GmbH Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.12.5 BSL BIOSERVICE Scientific Laboratories Munich GmbH Recent Developments
7.13 FDAS
7.13.1 FDAS Profile
7.13.2 FDAS Main Business
7.13.3 FDAS Batch Release Testing Products, Services and Solutions
7.13.4 FDAS Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.13.5 FDAS Recent Developments
7.14 ALS Laboratories (UK) Limited
7.14.1 ALS Laboratories (UK) Limited Profile
7.14.2 ALS Laboratories (UK) Limited Main Business
7.14.3 ALS Laboratories (UK) Limited Batch Release Testing Products, Services and Solutions
7.14.4 ALS Laboratories (UK) Limited Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.14.5 ALS Laboratories (UK) Limited Recent Developments
7.15 ADOH BV
7.15.1 ADOH BV Profile
7.15.2 ADOH BV Main Business
7.15.3 ADOH BV Batch Release Testing Products, Services and Solutions
7.15.4 ADOH BV Batch Release Testing Revenue (US$ Million) & (2019-2024)
7.15.5 ADOH BV Recent Developments
8 Industry Chain Analysis
8.1 Batch Release Testing Industrial Chain
8.2 Batch Release Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Batch Release Testing Sales Model
8.5.2 Sales Channel
8.5.3 Batch Release Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Wuxi Biologics
Merk
Eurofins BioPharma Product Testing
Samsung Biologics
Texcell
Intertek Group plc
ALS Life Sciences Europe
Kymos
Selvita
Excite Pharma Services
Smithers
BSL BIOSERVICE Scientific Laboratories Munich GmbH
FDAS
ALS Laboratories (UK) Limited
ADOH BV

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂